ICU Medical Income Statement 2025-2006 | ICUI

Brief overview of profit and loss at ICU Medical

This overview is based on financial performance over the past five years. According to figures from ICU Medical, revenue changed from 1.3 billion dollars to 2.2 billion dollars over five years. Across the full period, sales moved by +75.6%; the average annual rate was 11.9%. Top-line growth remained consistently strong over the period.

Gross profit was 461 million dollars at the start and 822 million dollars at the end of the period (+78.1%). Cost of revenue moved broadly in line with sales. Comparing the endpoints gives gross margins of 36.3% and 36.8%. The gross margin stayed within a similar range.

The operating result measured by EBITDA moved from 184 million dollars to 244 million dollars, or +32.5%. The operating result developed less favorably than sales. Comparing the endpoints gives EBITDA margins of 14.5% and 10.9%. The margin contraction indicates weaker operating efficiency.

Net income changed from 86.9 million dollars to 732 thousand dollars (−99.2%). The business generated less net income by the end of the period.

The market value of the business moved from $4.3 billion to $3.7 billion, or −15.4%. The financial trend was stronger than the market valuation.

Summary assessment

Positive developments coexist with areas of weakness. The constructive conclusion rests on steady gross profitability and sales growth. The most visible risks are weaker operating efficiency and a weaker final result. Future reports should be judged by revenue momentum, margins, and the conversion of sales into net income.